Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 3Phase NA 2Phase 4 2Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Venous Thromboembolism 2Venous Thrombosis 1Thrombosis 1Pulmonary Embolism 1Neoplasms 1

Interventions

fludarabine phosphate 9Cyclophosphamide 8Cyclosporine 7Busulfan 6Antilymphocyte Serum 6fludarabine 5Melphalan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Rivaroxaban 3Radiotherapy 3Methylprednisolone 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2ferric carboxymaltose 2apixaban 2Whole-Body Irradiation 2Therapeutics 2Methotrexate 2Heparin, Low-Molecular-Weight 2Hematologic Tests 2Genetic Counseling 2Fondaparinux 2Enoxaparin 2Educational Status 2Drug Therapy 2Dalteparin 2Cytarabine 2sulforaphane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Dalteparin × Classical hematology × Clear all
NCT06583330 2024-09-04

A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery

Beijing Friendship Hospital

Phase NA Not yet recruiting
1,448 enrolled
Classical hematology

Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡